Metabolic syndrome in patients with prostate cancer undergoing intermittent androgen-deprivation therapy

INTRODUCTION: The presence of metabolic syndrome in men with prostate cancer (PCa) undergoing androgen-deprivation therapy (ADT), especially intermittent type, has not been completely evaluated. The aim of this study is to evaluate metabolic syndrome in men with PCa undergoing intermittent ADT. METH...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Can Urol Assoc J
Glavni autori: Rezaei, Mohammadali Mohammadzadeh, Rezaei, Mohammadhadi Mohammadzadeh, Ghoreifi, Alireza, Kerigh, Behzad Feyzzadeh
Format: Artigo
Jezik:Inglês
Izdano: Canadian Medical Association 2016
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028214/
https://ncbi.nlm.nih.gov/pubmed/27695584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.3655
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items